Eli Lilly (LLY) PT Raised to $675 at Citi
Tweet
Share
E-mail
Get Alerts LLY Hot Sheet
Price: $1,160.08 +0.01%
Rating Summary:
30 Buy, 5 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 32
Rating Summary:
30 Buy, 5 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 32
Join SI Premium – FREE
Citi analyst Andrew Baum raised the price target on Eli Lilly (NYSE: LLY) to $675.00 (from $525.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Reiterates Overweight Rating on Eli Lilly (LLY)
- Lilly to buy Merida Biosciences for up to $2.875 billion
- Lilly to acquire Merida Biosciences to advance treatments for serious autoimmune and allergic diseases
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
